Pharmabiz

SystImmune & Bristol Myers Squibb announce izalontamab brengitecan doubles median PFS in patients with previously-treated EGFR-mutated NSCLC compared to chemotherapy in phase 3 ...

SystImmune & Bristol Myers Squibb announce izalontamab brengitecan doubles median PFS in patients with previously-treated EGFR-mutated NSCLC compared to chemotherapy in phase 3 PA ...
Pharmabiz

Mulk Technology launches AI-powered digital healthcare platform for India and global markets

Mulk Technology, a UAE-based healthcare technology company, announced its AI-powered digital healthcare platform for India ...
Pharmabiz

Mankind Pharma, AIOS and EBAI join hands for academic collaboration to enhance public awareness of corneal health

Mankind Pharma, AIOS and EBAI join hands for academic collaboration to enhance public awareness of corneal health: Our Bureau, Mumbai Tuesday, October 27, 2026, 17:20 Hrs [IST] Ma ...
Pharmabiz

OGT introduces first fusion MRD NGS Panel for AML to expand fusion detection at MRD-level sensitivity

OGT introduces first fusion MRD NGS Panel for AML to expand fusion detection at MRD-level sensitivity: Oxford, UK Tuesday, October 27, 2026, 16:00 Hrs [IST] OGT, a leading global ...
Pharmabiz

Cent raises $15 mn in Series A co-led by Blume Ventures and SPC; to build a full stack preventive health platform for India

Cent raises $15 mn in Series A co-led by Blume Ventures and SPC; to build a full stack preventive health platform for India: Our Bureau, Bengaluru Tuesday, October 27, 2026, 16:10 ...
Pharmabiz

Ascletis submits IND application to US FDA for ASC39, an oral small molecule selective amylin receptor agonist to treat obesity

Ascletis submits IND application to US FDA for ASC39, an oral small molecule selective amylin receptor agonist to treat obesity: Hong Kong Tuesday, October 27, 2026, 17:00 Hrs [IS ...
Pharmabiz

Indian hospitals should establish minimum standard for patient safety & quality care, says NITI Aayog member

Indian hospitals should establish minimum standard for patient safety & quality care, says NITI Aayog member: Our Bureau, New Delhi Tuesday, October 27, 2026, 15:50 Hrs [IST] Indi ...
Pharmabiz

Indoco’s AnaCipher receives approval from ANVISA Brazil for clinical and bioanalytical facilities

Indoco’s AnaCipher receives approval from ANVISA Brazil for clinical and bioanalytical facilities: Our Bureau, Mumbai Tuesday, October 27, 2026, 17:10 Hrs [IST] Indoco Remedies ...
Pharmabiz

HOSMAC develops Hospital Energy Analysis Tool to support energy planning of healthcare infrastructure

HOSMAC develops Hospital Energy Analysis Tool to support energy planning of healthcare infrastructure: Our Bureau, Bengaluru Tuesday, October 27, 2026, 16:20 Hrs [IST] HOSMAC, one ...
Pharmabiz

Oncologists note ‘Every Cancer Is Different; Treatment to be Tailored for Individual Patient’

India’s top oncologists note ‘Every Cancer Is Different; Treatment to be Tailored for Individual Patient’. Individualised drug therapy seeks to bring these factors together to help doctors determine ...
Pharmabiz

Ongoing MCADDI 2026 bridging medicinal chemistry, drug discovery and the future of therapeutics

Ongoing MCADDI 2026 bridging medicinal chemistry, drug discovery and the future of therapeutics: Our Bureau, Bengaluru Tuesday, October 27, 2026, 16:50 Hrs [IST] The ongoing Medic ...
Pharmabiz

Amway India announces expansion of physical presence across key markets

Amway India announces expansion of physical presence across key markets: Our Bureau, Mumbai Tuesday, October 27, 2026, 16:30 Hrs [IST] Accelerating its market presence and multi-y ...